Open tender · Germany · Contract notice
Open-House-Biologika-Rabattverträge 2025-26 - Insulin lispro (ATC: A10AB04, Wirkstärke: 100 U/ml)
Techniker Krankenkasse in Germany is inviting bids for “Open-House-Biologika-Rabattverträge 2025-26 - Insulin lispro (ATC: A10AB04, Wirkstärke: 100 U/ml)”. Bids close on 31 October 2027.